Morgan Stanley
SGHT icon

Morgan Stanley’s Sight Sciences SGHT Stock Holding History

Morgan Stanley’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Sell
155,222
-29,923
-16% -$138K ﹤0.01% 5291
2026
Q1 		$698K Sell
185,145
-44,218
-19% -$239K ﹤0.01% 5314
2025
Q4 		$1.82M Sell
229,363
-48,480
-17% -$310K ﹤0.01% 4877
2025
Q3 		$956K Sell
277,843
-55,553
-17% -$207K ﹤0.01% 5196
2025
Q2 		$1.38M Sell
333,396
-5,267
-2% -$17.6K ﹤0.01% 4936
2025
Q1 		$813K Buy
338,663
+59,629
+21% +$168K ﹤0.01% 5104
2024
Q4 		$1.02M Buy
279,034
+55,176
+25% +$251K ﹤0.01% 5082
2024
Q3 		$1.41M Buy
223,858
+60,353
+37% +$406K ﹤0.01% 4848
2024
Q2 		$1.09M Buy
163,505
+6,454
+4% +$38.2K ﹤0.01% 4906
2024
Q1 		$829K Sell
157,051
-39,928
-20% -$188K ﹤0.01% 5069
2023
Q4 		$1.02M Buy
196,979
+36,904
+23% +$114K ﹤0.01% 4917
2023
Q3 		$539K Sell
160,075
-478,208
-75% -$3.14M ﹤0.01% 5134
2023
Q2 		$5.28M Sell
638,283
-1,972
-0.3% -$17.8K ﹤0.01% 3732
2023
Q1 		$5.6M Sell
640,255
-60,946
-9% -$677K ﹤0.01% 3686
2022
Q4 		$8.56M Buy
701,201
+118
+0% +$1.12K ﹤0.01% 3225
2022
Q3 		$4.45M Buy
701,083
+463,240
+195% +$3.92M ﹤0.01% 3794
2022
Q2 		$2.14M Buy
237,843
+149,456
+169% +$1.32M ﹤0.01% 4488
2022
Q1 		$1.02M Buy
88,387
+23,396
+36% +$360K ﹤0.01% 4981
2021
Q4 		$1.14M Buy
64,991
+61,942
+2,032% +$1.36M ﹤0.01% 4974
2021
Q3 		$69K Buy
+3,049
New +$100K ﹤0.01% 6566

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley's SGHT Position: Q2 2026 in Review

Morgan Stanley reduced its Sight Sciences (SGHT) stake by 16% in Q2 2026, selling an estimated $138K and leaving 155,222 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #5291.

Morgan Stanley first reported a position in SGHT in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.56M in Q4 2022. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Morgan Stanley held 155,222 shares of Sight Sciences worth $841K as of Q2 2026.
  • Morgan Stanley sold 29,923 Sight Sciences shares in Q2 2026, an estimated $138K.
  • Sight Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5291 holding.
  • Morgan Stanley first reported a position in Sight Sciences in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Sight Sciences position peaked at $8.56M in Q4 2022.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.